infovisualinvesting - Infovisual Investing

infovisualinvesting

Infovisual Investing

Infovisual Investing is an #infographic content publisher covering the emerging growth investing space and an @infovisualmedia syndicate affiliate. Partnerships: https://bit.ly/IIN-partnerships Newsletter signup: https://bit.ly/IIN-signup

100 posts

Latest Posts by infovisualinvesting

infovisualinvesting
3 years ago

Eco Farm Holdings PBC (“Thrive Society”) – A Leading Technology-Enabled Cannabis Company, Secures Multi-Million Dollar Investment led by 32 Ventures Founder, Robert Wolf

http://www.ecofarm.ag


Tags
infovisualinvesting
4 years ago
Assessing Risk In OTC Stocks And A Market Driven By Investor Euphoria

Assessing risk in OTC stocks and a market driven by investor euphoria


Tags
infovisualinvesting
4 years ago
VolitionRx: First Commercial Canine Cancer Blood Test

VolitionRx: First commercial canine cancer blood test


Tags
infovisualinvesting
4 years ago
infovisualinvesting
4 years ago
WANdisco: One More Disruptor For The Emerging Growth Portfolio

WANdisco: One more disruptor for the emerging growth portfolio


Tags
infovisualinvesting
4 years ago
Assure Holdings: A Pure-play Opportunity In The Invasive Surgery Industry

Assure Holdings: A pure-play opportunity in the invasive surgery industry


Tags
infovisualinvesting
4 years ago
Midwest Energy Emissions Patent Litigation Among Stock Catalysts

Midwest Energy Emissions patent litigation among stock catalysts


Tags
infovisualinvesting
4 years ago
Emerging Growth Stock Ideas: Two Turnarounds And A Special Situation Stock

Emerging growth stock ideas: Two turnarounds and a special situation stock


Tags
infovisualinvesting
4 years ago
Else Nutrition Is Providing A Healthy Alternative To Mother’s Milk

Else Nutrition is providing a healthy alternative to mother’s milk


Tags
infovisualinvesting
4 years ago
Featured Emerging Growth Stock Portfolio: 7 Commercial-stage Disruptors

Featured emerging growth stock portfolio: 7 commercial-stage disruptors


Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News

Investing Visual Briefing 9/10/2020: Diffusion Pharma update & top investing news


Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News

Investing Visual Briefing 8/24/2020: Khiron Life Sciences earnings & top investing news


Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News

Investing Visual Briefing 8/13/2020: Green Organic Dutchman earnings & top investing news


Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News

Investing Visual Briefing 8/10/2020: FSD Pharma earnings & top investing news


Tags
infovisualinvesting
4 years ago
FSD Pharma Q2 2020 earnings: Received FDA approval to design clinical trial for COVID-19 treatment | Xanadu Investing
FSD Pharma released Q2 2020 earnings with key business updates related to its COVID-19 initiatives and other highlights.

Tags
infovisualinvesting
4 years ago
Tilray Q2 2020 earnings preview: Consensus EPS -$0.40 and revenue $54.99M estimates | Xanadu Investing
Tilray is scheduled to announce Q2 2020 earnings after market close on Monday, August 10th. The consensus EPS estimate is -$0.40.

Tags
infovisualinvesting
4 years ago
GW Pharmaceuticals Q2 2020 earnings: Epidiolex sales increase 64.6% | Xanadu Investing
GW Pharmaceuticals released earnings for its Q2 2020 that featured a 64.6% increase in Epidiolex sales to $117.7M.

Tags
infovisualinvesting
4 years ago
CV Sciences Q2 2020 earnings: Store count up 37.8% over the past year | Xanadu Investing
CV Sciences announced its earnings for Q2 2020 with a 37.8% retail store count increase to 6,325 compared to 4,591 at the end of Q2 2019.

Tags
infovisualinvesting
4 years ago
Greenlane Holdings Q2 2020 earnings: Vapor.com increased orders 74% to ~16,000 | Xanadu Investing
- Greenlane Holdings announced its Q2 2020 earnings with a 74% order increase to ~16,000 on its flagship DTC e-commerce platform, Vapor.com.

Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/7/2020: GW Pharmaceuticals earnings & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing space.

Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/6/2020: Cronos earnings review & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing spaces we currently cover. Our infographic cards are designed to maximize quick topic understanding and memorability.

Tags
infovisualinvesting
4 years ago
Aldeyra Therapeutics Q2 2020 earnings: EPS of -$0.25 beats by $0.09 with favorable cash runway | Xanadu Investing
Aldeyra Therapeutics released its earnings for Q2 2020 with GAAP EPS of -$0.25 – a $0.09 beat of analyst consensus.

Tags
infovisualinvesting
4 years ago
Silver One Resources announces exploration commencement on Nevada-based Cherokee Project | Xanadu Investing
Silver One Resources announced commencement of exploration on its wholly owned, Nevada-based Cherokee Project.

Tags
infovisualinvesting
4 years ago
Heritage Cannabis to acquire CBD strategic access company Opticann | Xanadu Investing
Heritage Cannabis entered into an agreement to acquire all shares of Colorado-based CBD company Opticann for initial consideration of C$5M and earn-outs.

Tags
infovisualinvesting
4 years ago
GW Pharmaceuticals Q2 2020 earnings preview: Consensus estimates of -$0.04 EPS and $124M revenue | Xanadu Investing
GW Pharmaceuticals is scheduled to announce Q2 earnings after market close on Thursday, August 6th. Its consensus estimates include -$0.04 EPS.

Tags
infovisualinvesting
4 years ago
WeedMD entered an exclusive agreement with MM Technology Holdings, LLC – owner of Mary’s Brands and its Mary’s Medicinals product line.

Tags
infovisualinvesting
4 years ago
Investing Visual Briefing 8/5/2020: Skeena Resources acquisition & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing spaces we currently cover.

Tags
Explore Tumblr Blog
Search Through Tumblr Tags